ArticleJournal of translational medicine2026
Single-cell and spatial transcriptomics identify SPP1 + trophoblast necroptosis as a potential contributor to late-onset preeclampsia via SPP1-CD44-mediated interaction with macrophages.
Article in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundLate-onset preeclampsia (LOPE) is a complex placental disorder characterized by inflammation and placental dysfunction, yet the underlying molecular mechanisms remain incompletely understood. Necroptosis, a regulated inflammatory form of cell death, has been implicated in various inflammation-associated diseases, but its role in LOPE has not been fully elucidated.
methodsWe performed an integrated analysis of single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics (ST) in placental tissues from LOPE and healthy pregnancies. Necroptosis activity was evaluated using gene-set scoring and validated by Western blotting and immunohistochemistry in human placentas. Pseudotime trajectory analysis, CellChat, and enrichment analysis were applied to characterize pathological cellular states and intercellular communication. Spatial deconvolution using RCTD was employed to map the localization and colocalization of specific cellular subtypes within placental niches. Functional validation was conducted in vivo using an L-NAME-induced preeclampsia-like mouse model in Mlkl knockout mice, together with multicolor immunofluorescence staining of human placental samples.
resultsSingle-cell transcriptomic profiling revealed marked cellular heterogeneity between LOPE and healthy placentas and identified activation of necroptosis-related pathways in trophoblast populations in LOPE. A distinct SPP1 + extravillous trophoblast (EVT) subtype associated with necroptosis signatures was identified. Trajectory analysis indicated that this SPP1 + EVT subset represented a pathological state enriched for cell-death and inflammatory signatures. Spatial transcriptomics demonstrated specific localization of SPP1 + EVTs within the placental microenvironment and their spatial proximity to macrophages. Cell-cell communication analysis further highlighted a prominent SPP1-CD44 signaling axis mediating interactions between SPP1 + EVTs and macrophages. In vivo, Mlkl knockout attenuated L-NAME-induced preeclampsia-like phenotypes and reduced placental SPP1 expression. Consistently, multicolor immunofluorescence confirmed increased abundance of SPP1 + EVTs and spatially adjacent macrophages in LOPE placentas.
conclusionsNecroptosis is a predominant trophoblast cell death pathway in LOPE. The SPP1-CD44 axis may mediate EVT-macrophage crosstalk, contributing to placental inflammation and dysfunction. These findings provide mechanistic insight into LOPE pathogenesis, nominate necroptosis as a potential therapeutic target, and highlight SPP1 as a promising biomarker candidate.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.